Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FH3H8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,607
Award facts
- Contract value 100% obligated
- $30,606.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $30,606.69. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 26, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent is a specialty pharmaceutical product used to treat various allergic and inflammatory conditions, representing the type of specialized medical commodity that DLA procures to support military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen holds a significant position within the federal medical supply chain and consistently demonstrates capability to fulfill competitive federal procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FH3H8?
SPE2DB25FH3H8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FH3H8 worth?
The government has obligated $30,607 on SPE2DB25FH3H8.
Is contract SPE2DB25FH3H8 an order under another contract?
Yes. SPE2DB25FH3H8 is a delivery order under SPE2DB22D1103, an indefinite delivery contract.
Was contract SPE2DB25FH3H8 competed?
The extent of competition for SPE2DB25FH3H8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award